SERPINE1 and COVID-19: Some studies have shown that plasma levels of both tPA and PAI-1 are elevated in hospitalized patients with COVID-19, indicating that effects of COVID-19 on fibrinolytic activity are variable and that a hyperfibrinolytic state exists in some patients with COVID-19 [69,70,71,72].